Literature DB >> 6140049

The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats.

C A Campbell, J R Parratt.   

Abstract

The effects of several beta-adrenoceptor blocking agents, [+), (-) and (+/-)-oxprenolol, p-oxprenolol, practolol, propranolol and timolol) were investigated on the ventricular arrhythmias occurring within the first 30 min of acutely ligating the main left coronary artery in anaesthetized rats. The degree of cardiac and vascular beta-adrenoceptor blockade was also assessed. All the compounds exhibited antiarrhythmic activity under these conditions. The degree of cardiac beta-adrenoceptor blockade required for this protection was less for the cardioselective agents, p-oxprenolol and practolol, than for the non-selective beta-adrenoceptor blocking agents. A comparison of the two isomers of oxprenolol demonstrated that the (-)-isomer markedly suppressed ischaemic arrhythmias (ventricular ectopic beats, incidence and duration of ventricular tachycardia and duration of ventricular fibrillation) more effectively than the (+)-isomer. Compounds possessing intrinsic sympathomimetic activity (ISA) caused less marked haemodynamic changes (in equivalent beta-blocking doses) than those that did not possess this ancillary property. The membrane stabilizing activity of oxprenolol and p-oxprenolol did not appear to contribute to the antiarrhythmic activity of these agents; however, the membrane stabilizing activity of propranolol may contribute to its effectiveness. In all the drugs studied, the main pharmacological property required to suppress early postischaemic arrhythmias is blockade of cardiac beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140049      PMCID: PMC2044941          DOI: 10.1111/j.1476-5381.1983.tb10539.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

Review 2.  Autonomic neural influences on the dysrhythmias resulting from myocardial infarction.

Authors:  P B Corr; R A Gillis
Journal:  Circ Res       Date:  1978-07       Impact factor: 17.367

3.  Acute coronary artery occlusion and cardiac sympathetic afferent nerve activity.

Authors:  Z J Bosnjak; E J Zuperku; R L Coon; J P Kampine
Journal:  Proc Soc Exp Biol Med       Date:  1979-06

4.  Left ventricular receptors activated by severe asphyxia and by coronary artery occlusion.

Authors:  P Thorén
Journal:  Acta Physiol Scand       Date:  1972-08

5.  Experimental coronary artery ligation in conscious dogs six months after bilateral cardiac sympathectomy.

Authors:  R A Fowlis; C T Sang; P M Lundy; S P Ahuja; H Colhoun
Journal:  Am Heart J       Date:  1974-12       Impact factor: 4.749

6.  Influence of beta blockade and chemical sympathectomy on myocardial function and arrhythmias in acute ischaemia.

Authors:  V Sethi; B Haider; S S Ahmed; H A Oldewurtel; T J Regan
Journal:  Cardiovasc Res       Date:  1973-11       Impact factor: 10.787

7.  Role of the nervous system in the arrhythmias produced by coronary occlusion in the cat.

Authors:  R A Gillis
Journal:  Am Heart J       Date:  1971-05       Impact factor: 4.749

8.  Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.

Authors:  E M Williams; E E Bagwell; B N Singh
Journal:  Cardiovasc Res       Date:  1973-03       Impact factor: 10.787

9.  Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion.

Authors:  D L Pearle; D Williford; R A Gillis
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

10.  Toward preventing coronary death from ventricular fibrillation.

Authors:  D G Julian
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

View more
  7 in total

1.  Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.

Authors:  M J Paletta; S Abraham; G N Beatch; M J Walker
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

2.  The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats.

Authors:  I Leprán; J R Parratt; L Szekeres; C L Wainwright
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

3.  The effects of the combined administration of beta-adrenoceptor antagonists and non-steroidal anti-inflammatory drugs on ligation-induced arrhythmias in rats.

Authors:  O Fagbemi
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

4.  The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat.

Authors:  M J Curtis; B A Macleod; M J Walker
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

5.  Effects of morphine on catecholamine release and arrhythmias evoked by myocardial ischaemia in rats.

Authors:  K Addicks; H Hirche; F M McDonald; W Polwin
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

6.  The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.

Authors:  S J Coker; J R Parratt
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

7.  Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.

Authors:  Y Hashimoto; R Hori; K Okumura; M Yasuhara
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.